SHAREHOLDER ALERT Kaskela Law LLC Announces Investigation of GreenLight Biosciences Holdings and Encourages Long-Term GRNA ENVI Shareholders to Contact the Firm
About 67% of Greenlight Biosciences' investor base is looking to short. The analysis of current outlook of investing in Greenlight Biosciences Holdings suggests that many traders are alarmed regarding Greenlight Biosciences' prospects. The current market sentiment, together with Greenlight Biosciences' historical and current headlines, can help investors time the market. In addition, many technical investors use Greenlight Biosciences stock news signals to limit their universe of possible portfolio assets.
Greenlight |
PRNewswire Kaskela Law LLC announces that it is investigating GreenLight Biosciences Holdings on behalf of the companys...
Read at prnewswire.com
 |
Greenlight Biosciences Fundamental Analysis
We analyze Greenlight Biosciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Greenlight Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Greenlight Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Beta
Beta Comparative Analysis
Greenlight Biosciences is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Greenlight Biosciences Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Greenlight Biosciences stock to make a market-neutral strategy. Peer analysis of Greenlight Biosciences could also be used in its relative valuation, which is a method of valuing Greenlight Biosciences by comparing valuation metrics with similar companies.
Peers
Greenlight Biosciences Related Equities
| FHTX | Foghorn Therapeutics | 4.75 | ||||
| CVKD | Cadrenal Therapeutics, | 3.20 | ||||
| NTRB | Nutriband | 0.83 | ||||
| LGVN | Longeveron LLC | 0.65 | ||||
| RNXT | RenovoRx | 0.99 | ||||
| REVB | Revelation Biosciences | 1.41 | ||||
| VRAX | Virax Biolabs | 2.34 | ||||
| ZVSA | ZyVersa Therapeutics | 3.42 | ||||
| BDRX | Biodexa Pharmaceticals | 3.48 | ||||
| LEXX | Lexaria Bioscience | 5.16 | ||||
| QNRX | Quoin Pharmaceuticals | 13.89 | ||||
| SNTI | Senti Biosciences | 17.76 |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Consideration for investing in Greenlight Stock
If you are still planning to invest in Greenlight Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Greenlight Biosciences' history and understand the potential risks before investing.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |